Bill > H4910

This bill aims to promote access and affordability of prescription drugs in Massachusetts. It establishes an Office of Pharmaceutical Policy and Analysis within the Health Policy Commission to analyze pharmaceutical spending data, produce reports, and advise on drug policy. The bill also requires the Health Policy Commission to assess and report on pharmacy deserts and the feasibility of state-sponsored drug manufacturing or distribution. Additionally, the bill regulates pharmacy benefit managers (PBMs) by requiring them to be licensed, prohibiting spread pricing and certain fees, and establishing requirements for audits and reimbursements. The bill also caps copayments for certain generic and brand-name drugs used to treat chronic conditions like diabetes, asthma, and heart disease for state employee, Medicaid, and private insurance plans.

https://malegislature.gov/Bills/193/H4910